A consulting practice with broad expertise in immuno-oncology, infectious disease and autoimmunity. Immunitas provides clients with a suite of tailored services that include preclinical development planning; expanding technology into new areas and new applications; analysis of competing technology, products and target product profiles; due diligence of science, technology, development plans and IP; and biotech facilities planning.Clients include large pharma, early-stage, mid-stage and publiclytraded biotech companies, venture capital and angel investors.For more information, please visit: www.immunitasconsulting.com